The PE Ratio as of July 2024 (TTM) for Altimmune, Inc. (ALT) is -4.22

According to Altimmune, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.22. This represents a change of -1.23% compared to the average of -4.27 of the last 4 quarters.

Altimmune, Inc. (ALT) Historical PE Ratio (quarterly & annually)

How has ALT PE Ratio performed in the past?

The mean historical PE Ratio of Altimmune, Inc. over the last ten years is -3.83. The current -4.22 PE Ratio has changed 10.92% with respect to the historical average. Over the past ten years (40 quarters), ALT's PE Ratio was at its highest in in the March 2015 quarter at 4.83. The PE Ratio was at its lowest in in the June 2014 quarter at -13.82.

Altimmune, Inc. (ALT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Altimmune, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Altimmune, Inc. (ALT) Average PE Ratio

How has ALT PE Ratio performed in the past?

The current PE Ratio of Altimmune, Inc. (ALT) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Altimmune, Inc. (ALT) PE Ratio vs. Peers

How is ALT’s PE Ratio compared to its peers?

Altimmune, Inc.’s PE Ratio is less than Reviva Pharmaceuticals Holdings, Inc. (-1.02), less than Athira Pharma, Inc. (-1.09), less than Fortress Biotech, Inc. (-0.68), greater than ACADIA Pharmaceuticals Inc. (-1844.58), greater than Cabaletta Bio, Inc. (-4.61), greater than Akero Therapeutics, Inc. (-9.30), greater than Terns Pharmaceuticals, Inc. (-7.36), greater than Madrigal Pharmaceuticals, Inc. (-12.81), greater than Inozyme Pharma, Inc. (-4.67), greater than Viking Therapeutics, Inc. (-75.29), greater than Anavex Life Sciences Corp. (-13.69), greater than Cassava Sciences, Inc. (-13.39), greater than INmune Bio, Inc. (-4.48), less than BioVie Inc. (-0.58), less than Cognition Therapeutics, Inc. (-2.78), greater than Ardelyx, Inc. (-19.90), less than Zura Bio Limited (-3.54), less than Hepion Pharmaceuticals, Inc. (-0.10), less than AVROBIO, Inc. (2.07), less than Verastem, Inc. (-0.75), less than X4 Pharmaceuticals, Inc. (-1.34), less than Galera Therapeutics, Inc. (-0.14), greater than Day One Biopharmaceuticals, Inc. (-6.65), greater than HOOKIPA Pharma Inc. (-16.23),

Build a custom stock screener for Altimmune, Inc. (ALT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Altimmune, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Altimmune, Inc. (ALT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Altimmune, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.